Vivani Medical Inc (VANI): Market Cap to Revenue

Symbol and logo of brand Vivani (VANI)

The price-to-sales multiple history demonstrates current dynamics, where the value of describes the current level for Vivani Medical, Inc. (VANI). Growth is supported by the creation of sustained-release drug delivery systems that foster strong patient loyalty. The business foundation is the replacement of frequent GLP-1 injections with semi-annual implants for obesity treatment, while the technical base is provided by certified high-precision laboratories with equipment in pristine condition.

VANI Vivani P/S Multiple (07/04/2022 - 11/15/2026)

Analytical breakdowns for Vivani Medical Inc (VANI)

- share price and consensus valuation forecast:
Price Performance Chart Vivani Medical Inc|VANI - Price Target Chart
- stock exchange capitalization data:
Market Valuation VANI|VANI - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Vivani Medical|VANI - Book Capitalization|Capitalization to Book Value Ratio vivani.com|VANI - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Vivani Medical, Inc.|VANI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Vivani Medical|VANI - Company Aggregate Debts|Debts to Book Capitalization Vivani Medical|VANI - Company Long-Term Debt|Company Short-Term Debt Vivani Medical|Intermediate Coverage Ratio vivani.com
- earnings and multiples data:
VANI - Net Profit|Expected Net Profit Vivani Medical, Inc.|VANI - Price to Earnings Ratio|Forward Price to Earnings Multiple Vivani|VANI - Price/Earnings to Growth Multiple|EV/EBITDA Multiple VANI|VANI - Operating profit EBITDA|Net earnings per share for the last four quarters Vivani Medical|VANI - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months vivani.com|VANI - Earnings per share growth in current year|Expected earnings per share growth for next year Vivani Medical, Inc.
- issuer revenue and sales details:
VANI - Revenue and Sales Volume|Company Expected Sales Volume Vivani Medical Inc|VANI - Price-to-Revenue Ratio|Market Cap to Projected Revenue Vivani Medical, Inc.|VANI - Revenue Growth YoY (Last 12 Months)
General company analysis:VANI Vivani Medical, Inc.
Core merchandise of Vivani Medical

The high volatility of Vivani Medical, Inc. (VANI) is driven by the absence of current cash flows pending the completion of implant clinical trials. The current stage of development leaves the business dependent on regulatory decisions, neutralizing operational resilience. By analyzing the price-to-sales ratio trend, an investor determines the value of a single dollar of sales, assessing market expectations for future growth. Ignoring the historical values of this multiple leads to overpaying for the asset during a correction period.

Competitors of Vivani Medical, Inc.

Market Cap to Revenue Boston Scientific Corporation BSX|P/S Multiple EW (Edwards Lifesciences)|ResMed Corp (RMD) - Price to Sales|Insulet Corp - P/S Multiple|ZBH (zimmerbiomet.com) - Market Cap to Revenue Ratio|COO: P/S Multiple|Market Cap to Revenue Ratio ALGN|GMED (NuVasive) - P/S Multiple|TransMedics Corp (TMDX) - Price-to-Revenue Coefficient|P/S Multiple ATEC|Market Cap to Revenue Artivion, Inc. AORT|P/S Multiple ENOV (enovis.com)|P/S Multiple Integra LifeSciences Corp IART|ESTA - Price-to-Revenue Ratio|BBNX: Price-to-Revenue Ratio|IRMD (IRADIMED CORPORATION) - Market Cap to Revenue|Embecta Corp. - Market Capitalization-to-Revenue Ratio|TNDM (Tandem Corp) - P/S Multiple|Price to Sales AxoGen Inc AXGN|Price-to-Revenue Ratio SI-BONE Inc (SIBN)|Orthofix Medical Inc. (OFIX) - Price-to-Revenue Multiple|P/S Multiple BVS (bioventus.com)|P/S Multiple OrthoPediatrics Inc. KIDS|Treace Medical Concepts Inc - P/S Multiple|Price-to-Revenue Coefficient Blade Air Mobility SRTA|Carlsmed (CARL) - Price-to-Revenue Ratio|Price-to-Sales Ratio RXST (RxSight Ophthalmic)|Price-to-Revenue Ratio clearpointneuro.com|Market Cap to Revenue Stereotaxis, Inc. (STXS)|P/S Multiple STIM|SGHT - Price to Sales|Price-to-Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Revenue Ratio|NSPR: Market Cap to Revenue|Jin Medical - Market Cap to Sales Volume|XTNT (Xtant Medical Holdings) - Market Cap to Revenue|Market Cap to Revenue Ratio NMTC|Price-to-Revenue Ratio Modular Medical Inc|Price to Sales Myomo Inc MYO|Market Cap to Revenue COCH (Envoy Medical, Inc.)|Price-to-Revenue Ratio VVOS (vivoslife.com)|enVVeno Medical Corp. - Market Cap to Revenue|Market Cap to Sales Volume SINT (sintx.com)|TNON - Price-to-Revenue Ratio|LFWD: Price-to-Revenue Ratio|autonomix.com (AMIX) - Price-to-Revenue Ratio|Price to Sales invobioscience.com (IVF)|BBLG (Bone Biologics Corp.) - P/S Multiple|Axonics Modulation Technologies (AXNX) - Price-to-Revenue Coefficient|Market Cap to Revenue BIOL (Biolase, Inc.)|Dynatronics - Market Cap to Revenue Ratio|Paragon 28, Inc. - Market Cap to Revenue|Price-to-Revenue Coefficient INVO Bio (INVO)